• en
  • it
  • de
  • Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios

    In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were impressed by its capabilities, the in-depth know-how of its employees and the rapid progress of the new steroid building construction. The latter is going to […]

    New ISO Certificates for FarmaBios (Gropello Cairoli, Italy)

    FarmaBios successfully completed the certification process in accordance with the ISO 45001:2018 standards. The new certificate is the last achievement of the list together with ISO 9001:2015 and ISO 14001:2015. With this certificate valid until 28th July 2023, FarmaBios presents objective evidence for the commitment to provide high quality and to works on continuous improvement […]

    Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and scalable supply of CBD, from clinical needs to full-scale commercial operations. “As a long-standing supplier of specialized […]